Case number 1:23-cv-00629
Astellas Pharma Inc. et al v. Evitalin LLC et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 11, 2024 | 66 | ORAL ORDER: In light of the continued stay, (D.I. 65 ), the Court hereby ORDERS that, by no later than 90 days from today's date, the parties shall submit a joint status report indicating their views on whether the stay should remain in place or be lifted. Ordered by Judge Christopher J. Burke on 10/11/2024. (smg) Modified on 10/15/2024 (smg). (Entered: 10/15/2024) (0) |
| Oct 11, 2024 | 65 | STIPULATION and [Proposed] Order to Stay by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Silver, Daniel) (Entered: 10/11/2024) (2) |
| Sep 6, 2024 | 64 | STIPULATION and [Proposed] Order to Further Stay by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Silver, Daniel) (Entered: 09/06/2024) (2) |
| Aug 8, 2024 | 63 | STIPULATION and Proposed Order to Stay by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 08/08/2024) (2) |
| Aug 5, 2024 | 62 | ORAL ORDER pursuant to Judge Burke ordering this case STAYED on 5/31/24, the Markman hearing scheduled for 8/8/24 is hereby cancelled. The parties are ordered to contact the Court within 5 days of the stay being lifted to reschedule the Markman hearing. Signed by Judge Joseph F. Bataillon on 8/5/24. (AEV) (Entered: 08/05/2024) (0) |
| Aug 5, 2024 | 61 | NOTICE requesting Clerk to remove Jacob Michael Bass as co-counsel.. (Joyce, Alexandra) (Entered: 08/05/2024) (2) |
| May 31, 2024 | 60 | STIPULATION and Proposed Order Regarding Case Scheduling by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 05/31/2024) (3) |
| May 30, 2024 | 59 | ORAL ORDER: The Markman hearing scheduled for 08/08/2024 at 11:00 AM, will be held in Courtroom 6B at the J. Caleb Boggs Federal Building, 844 N. King Street, Wilmington, Delaware, before Judge Joseph F. Bataillon. Signed by Judge Joseph F. Bataillon on 05/30/2024. (AEV) (Entered: 05/30/2024) (0) |
| May 23, 2024 | 58 | STIPULATION TO EXTEND TIME to Serve Answering Claim Construction Brief to June 3, 2024 - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 05/23/2024) (2) |
| May 16, 2024 | 57 | STIPULATION TO EXTEND TIME to Serve Answering Claim Construction Brief to May 23, 2024 - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 05/16/2024) (2) |
| Apr 25, 2024 | 56 | NOTICE OF SERVICE of Defendants' Responses to 1st Set of RFPs (Nos. 1-75) and Supplemental Responses to 1st Set of Rogs (Nos. 1-13) filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 04/25/2024) (2) |
| Apr 18, 2024 | 55 | NOTICE OF SERVICE of (1) Astellas' Opening Claim Construction Brief and (2) Declaration of Jacob Michael Bass, Esq. with Exhibits 1-4 filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 04/18/2024) (2) |
| Apr 1, 2024 | 54 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Interrogatories (Nos. 1-7) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 04/01/2024) (2) |
| Mar 28, 2024 | 53 | CLAIM Construction Chart by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Attachments: # 1 Exhibits B-E)(Joyce, Alexandra) (Entered: 03/28/2024) (0) |
| Mar 14, 2024 | 52 | NOTICE OF SERVICE of Proposed Claim Construction Terms and Proposed Constructions filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 03/14/2024) (2) |
| Mar 12, 2024 | 51 | NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 03/12/2024) (2) |
| Mar 7, 2024 | 50 | REDACTED VERSION of 47 Letter Joint Letter to the Court by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 03/07/2024) (4) |
| Mar 4, 2024 | 49 | NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Production (Nos. 1-12) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 03/04/2024) (2) |
| Mar 1, 2024 | 48 | STIPULATION TO EXTEND TIME for the Defendants to serve their initial invalidity contentions to March 11, 2024 - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 03/01/2024) (2) |
| Feb 29, 2024 | 47 | [SEALED] Joint Letter to The Honorable Christopher J. Burke from Joint Counsel. (Joyce, Alexandra) (Entered: 02/29/2024) (0) |
| Feb 15, 2024 | 46 | ORAL ORDER: Having reviewed the parties' interim status report, (D.I. 45), the Court hereby ORDERS as follows: (1) The Court will not be imposing a stay in this case absent the filing of a Motion to Stay, as set forth in the Scheduling Order, (D.I. 24 at 10-11). That being said, the Court notes that even if a Motion to Stay is filed on the grounds suggested in the letter, it is unlikely that a stay would be granted at this juncture.; and (2) The parties shall meet and confer about a process by which Defendants will produce sales information to Plaintiffs that would enable Plaintiffs to prepare a settlement demand. By no later than February 29, 2024, the parties shall file a joint letter of no more than two single-spaced pages with the Court summarizing what was discussed at the meet and confer and how (if at all) the parties have agreed to move forward on this front. Ordered by Judge Christopher J. Burke on 2/15/2024. (dlb) (Entered: 02/15/2024) (0) |
| Feb 8, 2024 | 45 | Interim STATUS REPORT (Joint) by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 02/08/2024) (4) |
| Feb 2, 2024 | 44 | NOTICE OF SERVICE of Defendants' Suppl Responses to Plaintiffs' 1st Set of Rogs (Nos. 1-13) filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 02/02/2024) (2) |
| Feb 2, 2024 | 43 | NOTICE OF SERVICE of Defendants' 1st Set of RFPs (Nos. 1-12) filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 02/02/2024) (2) |
| Feb 1, 2024 | 42 | STIPULATION TO EXTEND TIME to submit an Interim Status Report to February 8, 2024 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Silver, Daniel) (Entered: 02/01/2024) (2) |
| Jan 18, 2024 | 41 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Charts filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 01/18/2024) (2) |
| Jan 10, 2024 | 40 | Pro Hac Vice Fee - Credit Card Payment received for Jacob Michael Bass. ( re 39 MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass )( Payment of $ 50, receipt number ADEDC-4311115).(Joyce, Alexandra) (Entered: 01/10/2024) (0) |
| Jan 10, 2024 | 39 | MOTION for Pro Hac Vice Appearance of Attorney Jacob Michael Bass - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Attachments: # 1 Certification for Jacob Michael Bass)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 01/10/2024) (0) |
| Dec 26, 2023 | 38 | NOTICE of Change of Address by Peter Akawie Mazur (Mazur, Peter) (Entered: 12/26/2023) (2) |
| Dec 22, 2023 | 37 | NOTICE OF SERVICE of Plaintiffs' Production of Settlements and License Agreements (Production Volume ASTMIRA_EVIT_002 bearing production numbers ASTMIRA_EVIT_00003761 - ASTMIRA_EVIT_00004214) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 12/22/2023) (2) |
| Dec 11, 2023 | 36 | NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories (Nos. 1-13); and (2) Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-75) filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc..(Joyce, Alexandra) (Entered: 12/11/2023) (2) |
| Nov 29, 2023 | 35 | ORDER REGARDING PRODUCTION OF SETTLEMENT AND LICENSE AGREEMENTS. Signed by Judge Christopher J. Burke on 11/29/2023. (dlb) (dlb). (Entered: 11/29/2023) (2) |
| Nov 29, 2023 | 34 | Stipulated PROTECTIVE ORDER. Signed by Judge Christopher J. Burke on 11/29/2023. (dlb) (Entered: 11/29/2023) (30) |
| Nov 28, 2023 | 33 | PROPOSED ORDER regrading Production of Settlement and License Agreements by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 11/28/2023) (2) |
| Nov 28, 2023 | 32 | PROPOSED ORDER Stipulated Protective Order by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Joyce, Alexandra) (Entered: 11/28/2023) (30) |
| Nov 17, 2023 | 31 | STIPULATION TO EXTEND TIME the Deadlines for (1) the parties to file a Proposed Protective Order, and (2) Plaintiffs to submit to the Court a proposed Order requiring Plaintiffs to provide licenses and/or settlement agreements to Defendants to November 28, 2023 (from November 17, 2023) - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Silver, Daniel) (Entered: 11/17/2023) (2) |
| Nov 16, 2023 | 30 | NOTICE OF SERVICE of (1) Defendants' Rule 26(a)(1) Initial Disclosures; and (2) Defendants' Delaware Default Standard Paragraph 3 Disclosures filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 11/16/2023) (2) |
| Nov 16, 2023 | 29 | NOTICE OF SERVICE of (1) Plaintiffs' Fed. R. Civ. P. Rule 26(a)(1) Initial Disclosures; and (2) Plaintiffs' Disclosures Pursuant to Paragraph 3 of the Court's Default Standard for Discovery filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 11/16/2023) (2) |
| Nov 9, 2023 | 28 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lab Holdings I LLC for PharmaLabs, LLC filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 11/09/2023) (2) |
| Nov 3, 2023 | 27 | NOTICE OF SERVICE of Plaintiffs Astellas Pharma Inc., Astellas Ireland Co., Ltd., and Astellas Pharma Global Development, Inc.'s Identification of Accused Products, Asserted Patents, and Damages Model filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc..(Joyce, Alexandra) (Entered: 11/03/2023) (2) |
| Nov 2, 2023 | 26 | ANSWER to Amended Complaint, re: 19 Amended Complaint,, with Jury Demand by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.(Mazur, Peter) (Entered: 11/02/2023) (21) |
| Nov 2, 2023 | 25 | ORAL ORDER: The Court has reviewed the parties' joint letter regarding a proposed scheduling order. (D.I. 23) The court hereby ORDERS as follows: (1) With regard to the parties' positions on the limitations on depositions, the Court adopts Defendants' proposal.; (2) With regard to the parties' positions on whether the Court should permit expert declarations to be filed in connection with motions briefing, the Court adopts Plaintiffs' proposal; and (3) With regard to the parties' positions on claim construction briefing, the Court adopts Defendants' proposal. Ordered by Judge Christopher J. Burke on 11/2/2023. (dlb) (Entered: 11/02/2023) (0) |
| Nov 2, 2023 | 24 | SCHEDULING ORDER: Joinder of Parties due by 9/26/2024. Amended Pleadings due by 9/26/2024. Discovery due by 10/21/2024. Opening Expert Reports due by 1/31/2025. Rebuttal Expert Reports due by 3/3/2025. Reply Expert Reports due by 4/2/2025. Status Reports due by 2/1/2024, 7/22/2024, 1/16/2025. Dispositive Motions due by 6/10/2025. A Motion Hearing is set for 7/10/2025 at 11:00 AM before Judge Joseph F. Bataillon Claim Construction Opening Brief due by 4/18/2024. Claim Construction Answering Brief due by 5/16/2024. Claim Construction Reply Brief due by 6/4/2024. Claim Construction Surreply Brief due by 6/21/2024. Joint Claim Construction Brief due by 6/28/2024. A Markman Hearing is set for 8/8/2024 at 11:00 AM before Judge Joseph F. Bataillon. A Pretrial Conference is set for 10/17/2025 at 01:00 PM before Judge Christopher J. Burke. A 5-day Jury Trial is set for 11/3/2025 at 09:30 AM before Judge Joseph F. Bataillon. Please see Order for further details and deadlines. Signed by Judge Christopher J. Burke on 11/2/2023. (dlb) (Entered: 11/02/2023) (18) |
| Oct 27, 2023 | 23 | Letter to The Honorable Christopher J. Burke from Daniel M. Silver, Esq. regarding Scheduling Order Disputes and Three Most Significant Topics. (Attachments: # 1 Patent Case Scheduling Order, # 2 Case Management Checklist)(Silver, Daniel) (Entered: 10/27/2023) (0) |
| Oct 25, 2023 | 22 | STIPULATION and [Proposed] Order for the Extension of Time for Parties to Comply with the Court's September 25, 2023 Order (D.I. 18) to October 27, 2023 by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 10/25/2023) (2) |
| Oct 16, 2023 | 21 | STIPULATION and [Proposed] Order for Extension of Time for all Defendants to Answer or Otherwise Respond to the First Amended Complaint to November 2, 2023 re 19 Amended Complaint,, by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 10/16/2023) (2) |
| Oct 5, 2023 | 19 | Amended Complaint* (1) |
| Oct 5, 2023 | 20 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532 ;7,342,117 ;7,982,049 ;8,835,474 Amended. (Silver, Daniel) (Entered: 10/05/2023) (1) |
| Oct 5, 2023 | 19 | AMENDED COMPLAINT against Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC- filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma US, Inc., Astellas Pharma Global Development, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T)(Silver, Daniel) (Entered: 10/05/2023) (0) |
| Sep 25, 2023 | N/A | Pro Hac Vice Attorney Simon D. Roberts for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., and Astellas Pharma US, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00629-JFB-CJB, 1:23-cv-00689-JFB-CJB(mpb) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | N/A | Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., and Astellas Pharma US, Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | N/A | Pro Hac Vice Attorney Jayita Guhaniyogi for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., and Astellas Pharma US, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00629-JFB-CJB, 1:23-cv-00689-JFB-CJB(mpb) (Entered: 09/25/2023) (0) |
| Sep 25, 2023 | 18 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist (Checklist). Within thirty (30) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke/s "Rule 16 Scheduling Order - Patent"; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website.. Ordered by Judge Christopher J. Burke on 9/25/2023. (dlb) (Entered: 09/25/2023) (0) |
| Sep 21, 2023 | 17 | DECLARATION re 15 MOTION to Dismiss by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Attachments: # 1 Exhibit 1)(Mazur, Peter) (Entered: 09/21/2023) (0) |
| Sep 21, 2023 | 16 | OPENING BRIEF in Support re 15 MOTION to Dismiss filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC.Answering Brief/Response due date per Local Rules is 10/5/2023. (Mazur, Peter) (Entered: 09/21/2023) (18) |
| Sep 21, 2023 | 15 | MOTION to Dismiss - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Attachments: # 1 Text of Proposed Order)(Mazur, Peter) (Entered: 09/21/2023) (0) |
| Sep 21, 2023 | N/A | SO ORDERED D.I. 14 MOTION for Pro Hac Vice Appearance of Attorney Donald L. Jackson and Gregory A. Krauss filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. Ordered by Judge Christopher J. Burke on 9/21/2023. (dlb) (Entered: 09/21/2023) (0) |
| Sep 18, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Donald L. Jackson and Gregory A. Krauss - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. Motions referred to Christopher J. Burke.(Mazur, Peter) (Entered: 09/18/2023) (4) |
| Sep 11, 2023 | N/A | SO ORDERED D.I. 13 STIPULATION TO EXTEND TIME to Answer or Otherwise Respond to Complaint to September 21, 2023 filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. Ordered by Judge Christopher J. Burke on 9/11/2023. (dlb) (Entered: 09/11/2023) (0) |
| Sep 8, 2023 | 13 | STIPULATION TO EXTEND TIME to Answer or Otherwise Respond to Complaint to September 21, 2023 - filed by Evitalin LLC, PharmaLabs Holdco, Inc., PharmaLabs, LLC. (Mazur, Peter) (Entered: 09/08/2023) (2) |
| Aug 30, 2023 | N/A | Pro Hac Vice Attorney Vincent Li for Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., and Astellas Pharma US, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00629-JFB-CJB, 1:23-cv-00689-JFB-CJB(smg) (Entered: 08/30/2023) (0) |
| Aug 30, 2023 | N/A | SO ORDERED D.I. (12 in 1:23-cv-00629-JFB-CJB) MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi filed by Astellas Pharma US, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., and D.I. (10 in 1:23-cv-00689-JFB-CJB) MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi filed by Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc. Ordered by Judge Christopher J. Burke on 8/30/2023. Associated Cases: 1:23-cv-00629-JFB-CJB, 1:23-cv-00689-JFB-CJB(dlb) (Entered: 08/30/2023) (0) |
| Aug 24, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Simon D. Roberts, Jason A. Leonard, Vincent Li, and Jayita Guhaniyogi - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Attachments: # 1 Certifications)Motions referred to Christopher J. Burke.(Joyce, Alexandra) (Entered: 08/24/2023) (0) |
| Aug 1, 2023 | 11 | SO ORDERED D.I. 10 STIPULATION TO EXTEND TIME the Deadline for Defendants to Answer or Otherwise Respond to the Complaint to September 14, 2023 filed by Astellas Pharma US, Inc., Astellas Ireland Co., Ltd., Astellas Pharma Inc., Astellas Pharma Global Development, Inc., Set/Reset Answer Deadlines: All Defendants. Ordered by Judge Christopher J. Burke on 8/1/2023. (mlc) (Entered: 08/01/2023) (0) |
| Jul 28, 2023 | 10 | STIPULATION TO EXTEND TIME the Deadline for Defendants to Answer or Otherwise Respond to the Complaint to September 14, 2023 - filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., Astellas Pharma US, Inc.. (Silver, Daniel) (Entered: 07/28/2023) (2) |
| Jul 17, 2023 | 9 | SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma US, Inc., Astellas Pharma Global Development, Inc..PharmaLabs Holdco, Inc. served on 7/17/2023, answer due 8/7/2023. (Silver, Daniel) (Entered: 07/17/2023) (2) |
| Jul 10, 2023 | 8 | SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma US, Inc., Astellas Pharma Global Development, Inc..Evitalin LLC served on 7/10/2023, answer due 7/31/2023. (Silver, Daniel) (Entered: 07/10/2023) (1) |
| Jul 10, 2023 | 7 | SUMMONS Returned Executed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma US, Inc., Astellas Pharma Global Development, Inc..PharmaLabs, LLC served on 7/10/2023, answer due 7/31/2023. (Silver, Daniel) (Entered: 07/10/2023) (1) |
| Jun 20, 2023 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burkes portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (dlb) (Entered: 06/20/2023) (0) |
| Jun 20, 2023 | N/A | REMARK: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (dlb) (Entered: 06/20/2023) (0) |
| Jun 15, 2023 | 6 | ORAL ORDER - Pursuant to the filing of this case, the Court issues the following order: Magistrate Judge Burke shall issue a scheduling order when appropriate. Magistrate Judge Burke shall handle all nondispositive matters on all issues, except for Daubert motions, Markman hearings, and pretrial motions in limine. The parties have the right to file an appeal of the magistrate judge's order, and the same shall be decided by the undersigned. The magistrate judge shall likewise handle all discovery matters, scheduling, and pretrial conferences. If the parties believe the magistrate judge has a conflict of interest with this case, the parties shall so notify the Court. IT IS SO ORDERED. Signed by Judge Joseph F. Bataillon on 06/15/23. (AEV) (Entered: 06/15/2023) (0) |
| Jun 14, 2023 | N/A | Case Assigned to Judge Joseph F. Bataillon of the United States District Court for the District of Nebraska, due to related cases. Please include the initials of the Judge (JFB) after the case number on all documents filed. (rjb) (Entered: 06/14/2023) (0) |
| Jun 9, 2023 | 5 | Summonses Issued (please complete the top portion of the form and print out for use/service). (mkr) (Entered: 06/09/2023) (2) |
| Jun 9, 2023 | 4 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc., Astellas Pharma Inc., and Astellas Pharma US, Inc. (mkr) (Entered: 06/09/2023) (2) |
| Jun 9, 2023 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,346,532; 7,342,117; 7,982,049; 8,835,474; RE44,872. (mkr) (Entered: 06/09/2023) (1) |
| Jun 9, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 06/09/2023) (3) |
| Jun 9, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed with Jury Demand against Evitalin LLC, PharmaLabs Holdco, Inc., and PharmaLabs, LLC (Filing fee $ 402, receipt number ADEDC-4155347.) - filed by Astellas Pharma Inc., Astellas Ireland Co., Ltd., Astellas Pharma US, Inc., and Astellas Pharma Global Development, Inc. (Attachments: # 1 Exhibit A-S, # 2 Civil Cover Sheet)(mkr) (Entered: 06/09/2023) (0) |
